New Capital Management LP Bristol Myers Squibb CO Transaction History

New Capital Management LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 07, 2021	SELL	$59.17 - $69.31 $41,714 - $48,863	-705 Closed	0 $0
Q1 2020 Apr 17, 2020	SELL	$46.4 - $67.43 $11,924 - $17,329	-257 Reduced 26.72%	705 $39,000
Q3 2019 Oct 09, 2019	BUY	$42.77 - $50.71 $85 - $101	2 Added 0.21%	962 $48,000
Q2 2019 Jul 11, 2019	BUY	$44.62 - $49.34 $89 - $98	2 Added 0.21%	960 $44,000
Q1 2019 Apr 19, 2019	BUY	$45.12 - $53.8 $90 - $107	2 Added 0.21%	958 $46,000
Q4 2018 Jan 18, 2019	SELL	$48.76 - $63.23 $8,923 - $11,571	-183 Reduced 16.07%	956 $50,000
Q3 2018 Oct 05, 2018	BUY	$55.19 - $62.25 $10,320 - $11,640	187 Added 19.64%	1,139 $71,000
Q2 2018 Jul 09, 2018	BUY	$50.53 - $62.98 $101 - $125	2 Added 0.21%	952 $53,000
Q1 2018 Apr 12, 2018	BUY	$59.92 - $68.98 $59 - $68	1 Added 0.11%	950 $60,000
Q4 2017 Jan 19, 2018	BUY	$59.94 - $65.35 $179 - $196	3 Added 0.32%	949 $58,000
Q3 2017 Oct 23, 2017	BUY	$55.23 - $63.74 $52,247 - $60,298	946	946 $60,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of New Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on New Capital Management LP with notifications on news.